Pulmonary Diseases

Challenges in quantitative evaluation of Chest CT exams

thoracic vcar

Automated lung segmentation and quantitative measurements to aid in the assessment and follow-up of lung diseases

  • AUTOMATED
    lung and airway
    segmentation



  • AUTOMATIC
    calculation of abnormal
    hounsfield ranges



  • EFFICIENTLY
    identify and report
    regions of relative
    hypo-perfusion with the
    GSI Pulmonary Perfusion
    feature

  • Complete reading workflow solution featuring:

    • Automated segmentation of lungs and airways
    • Individual lobe segmentation and visualization
    • Parenchyma analysis with customizable presets to identify different ranges of HU variances within the segmented lung fields
    • One-touch 3D airway tracking and automated measurements of wall thickness for airway analysis
    • Automatic analysis of GSI pulmonary studies
    • Display relative perfusion map based on GSI iodine concentration in lung parenchyma

Supporting Materials

1. Forum of International Respiratory Societies. The Global Impact of Respiratory Disease – Second Edition. Sheffi eld, European Respiratory Society, 2017.
2. IMV 2019 CT Market Outlook Report.

JB00757IN

WIPRO GE HEALTHCARE PVT LTD
No. 4, Kadugodi Industrial Area,
Bangalore 560067,
Karnataka, India
CIN: U33111KA1990PTC01606
1800-102-2977 / +91 80 4180 1290
India.eCommerce@ge.com
Grievance Officer: Nestor J. Rivera
Chief Privacy Counsel/Officer, GE HealthCare